The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors
Open accessAbstract
CRISPR-Cas base-editor technology enables targeted nucleotide alterations, and is being increasingly used for research and potential therapeutic applications 1,2. The most widely used cytosine base editors (CBEs) induce deamination of DNA cytosines using the rat APOBEC1 enzyme, which is targeted by a linked Cas protein-guide RNA complex 3,4. Previous studies of the specificity of CBEs have identified off-target DNA edits in mammalian cells 5,6. Here we show that a CBE with rat APOBEC1 can cause extensive transcriptome-wide deamination of RNA cytosines in human cells, inducing tens of thousands of C-to-U edits with frequencies ranging from 0.07% to 100% in 38-58% of expressed genes. CBE-induced RNA edits occur in both protein-coding and non-protein-coding sequences and generate missense, nonsense, splice site, and 5' and 3' untranslated region mutations. We engineered two CBE variants bearing mutations in rat APOBEC1 that substantially decreased the number of RNA edits (by more than 390-fold and more than 3,800-fold) in human cells. These variants also showed more precise on-target DNA editing than the wild-type CBE and, for most guide RNAs tested, no substantial reduction in editing efficiency. Finally, we show that an adenine base editor 7 can also induce transcriptome-wide RNA edits. These results have implications for the use of base editors in both research and clinical settings, illustrate the feasibility of engineering improved variants with reduced RNA editing activities, and suggest the need to more fully define and characterize the RNA off-target effects of deaminase enzymes in base editor platforms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“they create new formats of off-target effects such as RNA editing and sgRNA-independent DNA editing”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Grünewald et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While these methods have been used in cultured cells, they are not yet ready for clinical use until matters of specificity 33,34 and delivery are addressed.”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“The RNA off-target effects can be detected by RNA-seq”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Grünewald et al., 2019
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although CBE and ABE greatly reduce the classic off-target effects of CRISPR/Cas9 systems”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Grünewald et al., 2019
Experimental — accuracy not yet measuredIn the citing paper
“These systems induce transient conversions, potentially minimising undesired physiological changes compared to DNA editing. 90”
From Innovative therapies for inherited retinal dystrophies: navigating DNA, RNA, and protein approaches (2025) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
WebLogo: A Sequence Logo Generator: Figure 1Preprint
Crooks, G. E., Hon, G. C., Chandonia, J., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,418
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Enzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 10,088
The Phyre2 web portal for protein modeling, prediction and analysis
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015) · Nature Protocols · doi:10.1038/nprot.2015.053 · Cited by 9,652
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Cited by
Sorted by citations
Items 101–200 of 671
He, Y., Zhou, X., Chang, C. H., Chen, G., Liu, W., Li, G., Fan, X., Sun, M., Miao, C., Huang, Q., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.01.021 · Cited by 79
Broadening the GMO risk assessment in the EU for genome editing technologies in agriculture
Kawall, K., Cotter-Howells, J. D., & Then, C. (2020) · Environmental Sciences Europe · doi:10.1186/s12302-020-00361-2 · Cited by 84
Precise genome-editing in human diseases: mechanisms, strategies and applications
Zheng, Y., Li, Y., Zhou, K., Li, T., VanDusen, N. J., & Hua, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01750-2 · Cited by 91
Expanding C–T base editing toolkit with diversified cytidine deaminases
Cheng, T., Li, S., Yuan, B., Wang, X., Zhou, W., & Qiu, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-11562-6 · Cited by 74
Expanding the genome-targeting scope and the site selectivity of high-precision base editors
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2020) · Nature Communications · doi:10.1038/s41467-020-14465-z · Cited by 79
Deep learning models to predict the editing efficiencies and outcomes of diverse base editors
Kim, N., Choi, S.-C., Kim, S., Song, M., Seo, J. H., Min, S., Park, J., Cho, S., & Kim, S. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01792-x · Cited by 78
Revolutionizing CRISPR technology with artificial intelligence
Kim, M., Go, M.-J., Kang, S.-H., Jeong, S.-H., & Lim, K. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01462-9 · Cited by 87
Li, C., Wang, H., Georgakopoulou, A., Gil, S., Yannaki, E., & Lieber, A. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.001 · Cited by 73
A Cas-embedding strategy for minimizing off-target effects of DNA base editors
Liu, Y., Zhou, C., Huang, S., Dang, L., Yu, W., He, J., Zhou, Y., Mao, S., Tao, W., Zhang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19690-0 · Cited by 70
Systematic optimization of Cas12a base editors in wheat and maize using the ITER platform
Gaillochet, C., Fernández, A. P., Goossens, V., D’Halluin, K., Drozdzecki, A., Shafie, M., Duyse, J. V., Isterdael, G. V., Gonzalez, C., Vermeersch, M., et al. (2023) · Genome biology · doi:10.1186/s13059-022-02836-2 · Cited by 78
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy
Mbakam, C. H., Lamothe, G., Tremblay, G., & Tremblay, J. P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01197-9 · Cited by 81
Structure-guided engineering of adenine base editor with minimized RNA off-targeting activity
Li, J., Yu, W., Huang, S., Wu, S., Li, L., Zhou, J., Cao, Y., Huang, X., & Qiao, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-22519-z · Cited by 72
Zhang, E., Neugebauer, M. E., Krasnow, N. A., & Liu, D. R. (2024) · Nature Communications · doi:10.1038/s41467-024-45969-7 · Cited by 68
Gene editing and its applications in biomedicine
Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W. C., Wu, Z., Zhou, Z. L., Chen, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2057-0 · Cited by 66
Liang, Y., Xie, J., Zhang, Q., Wang, X., Gou, S., Lin, L., Chen, T., Ge, W., Zhuang, Z., Lian, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac353 · Cited by 68
Detect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors
Lei, Z., Meng, H., Lv, Z., Liu, M., Zhao, H., Wu, H., Zhang, X., Liu, L., Zhuang, Y., Yin, K., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01172-w · Cited by 67
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
Bloomer, H., Khirallah, J., Li, Y., & Xu, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114087 · Cited by 75
Li, Z., Wang, J., Xu, J.-P., Yang, X. F., & Yang, X. F. (2023) · Military Medical Research · doi:10.1186/s40779-023-00447-x · Cited by 72
The use of new CRISPR tools in cardiovascular research and medicine
Nishiga, M., Liu, C., Qi, L. S., & Wu, J. C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00669-3 · Cited by 71
RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering
Smargon, A. A., Shi, Y. J., & Yeo, G. W.-M. (2020) · Nature Cell Biology · doi:10.1038/s41556-019-0454-7 · Cited by 64
Gao, R., Fu, Z.-C., Li, X., Wang, Y., Wei, J., Li, G., Wang, L., Wu, J., Xue, W., Huang, X., et al. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0080 · Cited by 74
Xu, W., Zhang, S., Qin, H., & Yao, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05957-3 · Cited by 74
Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing
Li, J., Hong, S., Chen, W., Zuo, E., & Yang, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.002 · Cited by 66
Exploring C-To-G Base Editing in Rice, Tomato, and Poplar
Sretenovic, S., Liu, S., Li, G., Cheng, Y., Fan, T., Xu, Y., Zhou, J., Zheng, X., Coleman, G. D., Zhang, Y., et al. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.756766 · Cited by 63
McGrath, E. L., Shin, H., Zhang, L., Phue, J., Wu, W. W., Shen, R., Jang, Y.-Y., Revollo, J. R., & Ye, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-13342-8 · Cited by 63
CRISPR nuclease off-target activity and mitigation strategies
Wienert, B., & Cromer, M. K. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.1050507 · Cited by 66
Functional Features and Current Applications of the RNA‐Targeting Type VI CRISPR‐Cas Systems
Perčulija, V., Lin, J., Zhang, B., & Ouyang, S. (2021) · Advanced Science · doi:10.1002/advs.202004685 · Cited by 60
Madison, B., Patil, D. P., Richter, M., Li, X., Tong, M., Cranert, S. A., Wang, X., Martin, R. M., Xi, H., Tan, Y., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.003 · Cited by 61
Jo, D. H., Jang, H., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.11.021 · Cited by 61
Striated muscle-specific base editing enables correction of mutations causing dilated cardiomyopathy
Grosch, M., Schraft, L., Chan, A., Küchenhoff, L., Rapti, K., Ferreira, A.-M., Kornienko, J., Li, S., Radke, M. H., Krämer, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39352-1 · Cited by 61
Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression
Cheng, L., Li, Y., Qi, Q., Xu, P., Feng, R., Palmer, L. E., Chen, J., Wu, R., Yee, T., Zhang, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00861-8 · Cited by 59
Recent advances in therapeutic gene-editing technologies
Liu, D., Cao, D., & Han, R. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.026 · Cited by 70
Wang, J., Zhang, C., & Feng, B. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15039 · Cited by 61
Rose, J. C., Popp, N. A., Richardson, C. D., Stephany, J. J., Mathieu, J., Wei, C. T., Corn, J. E., Maly, D. J., & Fowler, D. M. (2020) · Nature Communications · doi:10.1038/s41467-020-16542-9 · Cited by 61
Development of Highly Efficient Dual‐AAV Split Adenosine Base Editor for In Vivo Gene Therapy
Chen, Y., Zhi, S., Liu, W., Wen, J., Hu, S., Cao, T., Sun, H., Li, Y., Huang, L. T., Liu, Y., et al. (2020) · Small Methods · doi:10.1002/smtd.202000309 · Cited by 57
Improvement of base editors and prime editors advances precision genome engineering in plants
Hua, K., Han, P., & Zhu, J. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab591 · Cited by 62
Cytosine base editor 4 but not adenine base editor generates off-target mutations in mouse embryos
Lee, H., Smith, H. E., Liu, C., Willi, M., & Hennighausen, L. G. (2020) · Communications Biology · doi:10.1038/s42003-019-0745-3 · Cited by 61
Masarwy, R., Stotsky‐Oterin, L., Elisha, A., Hazan‐Halevy, I., & Peer, D. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115359 · Cited by 59
Emerging trends in prime editing for precision genome editing
Lee, J., Kweon, J., & Kim, Y. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01463-8 · Cited by 70
Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems
Zheng, N., Li, L., & Wang, X. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.34 · Cited by 59
Cytosine base editing systems with minimized off-target effect and molecular size
Li, A., Mitsunobu, H., Yoshioka, S., Suzuki, T., Kondo, A., & Nishida, K. (2022) · Nature Communications · doi:10.1038/s41467-022-32157-8 · Cited by 57
Yuan, T., Yan, N., Fei, T., Zheng, J., Meng, J., Li, N., Liu, J., Zhang, H., Xie, L., Ying, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25217-y · Cited by 55
Methods and applications of CRISPR/Cas system for genome editing in stem cells
Yang, G., & Huang, X. (2019) · Cell Regeneration · doi:10.1016/j.cr.2019.08.001 · Cited by 55
Nazir, R., Mandal, S., Mitra, S., Ghorai, M., Das, N., Jha, N. K., Majumder, M., Pandey, D. K., & Dey, A. (2022) · Physiologia Plantarum · doi:10.1111/ppl.13642 · Cited by 60
Li, M., Zhong, A., Wu, Y., Sidharta, M., Beaury, M. W., Zhao, X., Studer, L., & Zhou, T. (2022) · Nature Communications · doi:10.1038/s41467-022-34045-7 · Cited by 57
Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions
Liu, Z., Chen, S., Shan, H., Jia, Y., Chen, M., Song, Y., Lai, L., & Li, Z. (2020) · BMC Biology · doi:10.1186/s12915-020-00849-6 · Cited by 53
Adenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 53
DNA base editing in nuclear and organellar genomes
Tan, J., Forner, J., Karcher, D., & Bock, R. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.06.015 · Cited by 57
Genome- and transcriptome-wide off-target analyses of an improved cytosine base editor
Randall, L. B., Sretenovic, S., Wu, Y., Yin, D., Zhang, T., Eck, J. M. V., & Qi, Y. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab264 · Cited by 51
In the business of base editors: Evolution from bench to bedside
Porto, E. M., & Komor, A. C. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002071 · Cited by 53
Han, W., Qiu, H.-Y., Sun, S., Fu, Z.-C., Wang, G., Qian, X., Wang, L., Zhai, X., Jia, W. P., Wang, Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.10.007 · Cited by 53
RNA-targeting strategies as a platform for ocular gene therapy
Kumar, S., Fry, L. E., Wang, J.-H., Martin, K. R., Hewitt, A. W., Chen, F. K., & Liu, G.-S. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101110 · Cited by 51
Guyon, A., Rousseau, J., Bégin, F.-G., Bertin, T., Lamothe, G., & Tremblay, J. P. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.02.032 · Cited by 55
Kondo, K., & Taguchi, C. (2022) · Food Safety · doi:10.14252/foodsafetyfscj.d-21-00016 · Cited by 49
Modeling the complex genetic architectures of brain disease
Fernando, M. B., Ahfeldt, T., & Brennand, K. (2020) · Nature Genetics · doi:10.1038/s41588-020-0596-3 · Cited by 48
Lyu, P., Lu, Z., Cho, S.-I., Yadav, M., Yoo, K. W., Atala, A., Kim, J., & Lu, B. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0095 · Cited by 50
Highly efficient base editing with expanded targeting scope using SpCas9‐NG in rabbits
Liu, Z., Shan, H., Chen, S., Chen, M., Song, Y., Lai, L., & Li, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201901587r · Cited by 46
Guo, J., Yu, W., Li, M., Chen, H., Liu, J., Xue, X., Lin, J., Huang, S., Shu, W., Huang, X., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2023.04.012 · Cited by 49
Kyrochristos, I. D., & Roukos, D. H. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101894 · Cited by 49
Knipping, F., Newby, G. A., Eide, C. R., McElroy, A. N., Nielsen, S. C., Smith, K. D., Fang, Y., Cornu, T. I., Costa, C., Gutiérrez-Guerrero, A., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.026 · Cited by 53
Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing
Sayed, S., Sidorova, O. A., Hennig, A., Augsburg, M., Vesga, C. P. C., Abohawya, M., Schmitt, L. T., Sürün, D., Stange, D. E., Mircetic, J., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2519 · Cited by 51
An adenine base editor variant expands context compatibility
Xiao, Y., Wu, Y., & Tang, W. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01994-3 · Cited by 48
Current trends in gene recovery mediated by the CRISPR-Cas system
Jang, H., Song, B., Hwang, G., & Bae, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0466-1 · Cited by 49
Huang, C., Li, G., Wu, J., Liang, J., & Wang, X. (2021) · Genome biology · doi:10.1186/s13059-021-02305-2 · Cited by 48
Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing
Zhang, X., Li, T., Ou, J., Huang, J., & Liang, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00838-7 · Cited by 47
Efficient Correction of a Hypertrophic Cardiomyopathy Mutation by ABEmax-NG
Ma, S., Jiang, W., Liu, X., Lu, W., Qi, T., Wei, J., Wu, F., Chang, Y., Zhang, S., Song, Y., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318674 · Cited by 45
ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation
Sheriff, A., Guri, I., Żebrowska-Różańska, P., Llopis-Hernández, V., Brooks, I. R., Tekkela, S., Subramaniam, K. S., Gebrezgabher, R., Naso, G., Petrova, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24184-8 · Cited by 49
Controllable genome editing with split-engineered base editors
Berríos, K. N., Evitt, N. H., DeWeerd, R. A., Ren, D., Luo, M., Barka, A., Wang, T., Bartman, C., Lan, Y., Green, A. M., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00880-w · Cited by 44
Recent Therapeutic Gene Editing Applications to Genetic Disorders
Deneault, É. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050255 · Cited by 54
Base editing-mediated splicing correction therapy for spinal muscular atrophy
Lin, X., Chen, H., Lu, Y., Hong, S., Hu, X., Gao, Y., Lai, L., Li, J.-J., Wang, Z., Ying, W., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0304-y · Cited by 44
Technologies and Computational Analysis Strategies for CRISPR Applications
Clement, K., Hsu, J. Y., Canver, M. C., Joung, J. K., & Pinello, L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.012 · Cited by 45
Self-citationPAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics
Acharya, S., Ansari, A. H., Das, P. K., Hirano, S., Aich, M., Rauthan, R., Mahato, S., Maddileti, S., Sarkar, S., Kumar, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49233-w · Cited by 47
Advances in genome editing for genetic hearing loss
Ding, N., Lee, S., Lieber-Kotz, M., Yang, J., & Gao, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.001 · Cited by 43
Inflammation-driven deaminase deregulation fuels human pre-leukemia stem cell evolution
Jiang, Q., Isquith, J. M., Ladel, L., Mark, A., Holm, F., Mason, C. N., He, Y., Mondala, P. K., Oliver, I., Pham, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108670 · Cited by 45
Off-target effects of base editors: what we know and how we can reduce it
Slesarenko, Y. S., Лавров, А. В., & Smirnikhina, S. (2021) · Current Genetics · doi:10.1007/s00294-021-01211-1 · Cited by 45
Using Gene Editing Approaches to Fine-Tune the Immune System
Pavlovic, K., Tristán‐Manzano, M., Maldonado‐Pérez, N., Cortijo-Gutierréz, M., Sánchez-Hernández, S., Justicia-Lirio, P., Carmona-Luque, M. D., Herrera, C., Martín, F., & Benabdellah, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570672 · Cited by 49
Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide
Liu, Z., Chen, S., Jia, Y., Shan, H., Chen, M., Song, Y., Lai, L., & Li, Z. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1775-2 · Cited by 35
Gene Therapy and Gene Editing for β-Thalassemia
Christakopoulos, G. E., Telange, R., Yen, J. S., & Weiss, M. J. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.012 · Cited by 43
Askary, A., Chen, W., Choi, J., Du, L. Y., Elowitz, M. B., Gagnon, J. A., Schier, A. F., Seidel, S., Shendure, J., Stadler, T., et al. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00788-w · Cited by 40
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria
Grisch‐Chan, H. M., Schwank, G., Harding, C. O., & Thöny, B. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.111 · Cited by 45
Genome-editing strategies for treating human retinal degenerations
Quinn, J., Musa, A., Kantor, A., McClements, M. E., Cehajic-Kapetanovic, J., MacLaren, R. E., & Xue, K. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.231 · Cited by 41
Alariqi, M., Ramadan, M., Yu, L., Hui, F., Hussain, A., Zhou, X., Yu, Y., Zhang, X., & Jin, S. (2025) · Advanced Science · doi:10.1002/advs.202416331 · Cited by 42
GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
Zuo, E., Sun, Y., Wu, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2020) · Nature Protocols · doi:10.1038/s41596-020-0361-1 · Cited by 43
CRISPR-based strategies for targeted transgene knock-in and gene correction
Lau, C., Tin, C., & Suh, Y. (2020) · Faculty Reviews · doi:10.12703/r/9-20 · Cited by 46
Tiwari, M., Trivedi, P. K., & Pandey, A. K. (2020) · Food and Energy Security · doi:10.1002/fes3.258 · Cited by 42
Sun, N., Zhao, D., Li, S., Zhang, Z., Bi, C., & Zhang, X. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.023 · Cited by 40
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Ail, D., Malki, H., Zin, E. A., & Dalkara, D. (2023) · The Application of Clinical Genetics · doi:10.2147/tacg.s383453 · Cited by 40
Sickle Cell Disease: From Genetics to Curative Approaches
Hardouin, G., Magrin, E., Corsia, A., Cavazzana, M., Miccio, A., & Semeraro, M. (2023) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120122-081037 · Cited by 40
Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 46
Jun, S., Lim, H., Chun, H., Lee, J. H., & Bang, D. (2020) · Communications Biology · doi:10.1038/s42003-020-0888-2 · Cited by 39
Paving the way towards precise and safe CRISPR genome editing
Śledziński, P., Dabrowska, M., Nowaczyk, M., & Olejniczak, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107737 · Cited by 43
Progress in Gene-Editing Technology of Zebrafish
Li, Y., Jia, Z., Zhang, S., & He, X. (2021) · Biomolecules · doi:10.3390/biom11091300 · Cited by 46
Programmable RNA base editing with a single gRNA-free enzyme
Han, W., Huang, W., Wei, T., Ye, Y., Mao, M., & Wang, Z. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac713 · Cited by 39
The Design and Application of DNA-Editing Enzymes as Base Editors
Rallapalli, K. L., & Komor, A. C. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052521-013938 · Cited by 44
Miyahira, A. K., Sharp, A., Ellis, L., Jones, J. C., Kaochar, S., Larman, H. B., Quigley, D. A., Ye, H., Simons, J. W., Pienta, K. J., et al. (2019) · The Prostate · doi:10.1002/pros.23934 · Cited by 40
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications
Xu, X., Hulshoff, M. S., Tan, X., Zeisberg, M., & Zeisberg, E. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093038 · Cited by 41
Multiplex precise base editing in cynomolgus monkeys
Zhang, W., Aida, T., del Rosario, R. C. H., Wilde, J. J., Ding, C., Zhang, X., Baloch, Z., Huang, Y., Tang, Y., Li, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16173-0 · Cited by 42
A Tale of Two Moieties: Rapidly Evolving CRISPR/Cas-Based Genome Editing
Yang, L. C., & Chen, J. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.06.003 · Cited by 38
Base editing and prime editing in laboratory animals
Caso, F., & Davies, B. (2021) · Laboratory Animals · doi:10.1177/0023677221993895 · Cited by 41
Human cell based directed evolution of adenine base editors with improved efficiency
Fu, J., Li, Q., Liu, X., Tu, T., Lv, X., Yin, X., Lv, J., Song, Z., Qu, J., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26211-0 · Cited by 35
Metadata
- Authors
- Grünewald, J., Zhou, R., Garcia, S. P., Iyer, S., Lareau, C. A., Aryee, M. J., & Joung, J. K.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Joung, J. Keith
- ORCID
- Venue
- Nature
- Published
- 2019-04-17
- Volume
- 569
- Issue
- 7756
- Pages
- 433-437
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6657343
- OpenAlex
- W2939749480
- Cited by
- 663
- References
- 37
- Citations by year
- 2026: 66 · 2025: 74 · 2024: 80 · 2023: 100 · 2022: 84 · 2021: 106 · 2020: 104 · 2019: 48
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Human Genome Research Institute (RM1HG009490)
- National Institute of General Medical Sciences (R35GM118158)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- cytosine base editors, APOBEC1, RNA editing, off-target effects, adenine base editors, deaminase activity, human cells
- MeSH terms
- APOBEC-1 Deaminase, Gene Editing, Animals, Base Sequence, Cytosine, Deamination, Humans, Mutation, RNA, Substrate Specificity, RNA Editing, Rats, Hep G2 Cells, HEK293 Cells, Transcriptome, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review